TickerFacts.

Fresenius Medical Care AG (FMS): Cost of Revenue

Annual figures by period end, from SEC filings.

Not updated since 2016-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2010-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$12.13B
Year ended 2016-12-31
+7.1%
3-year compound annual growth
+7.6%
5-year compound annual growth
2007-12-31: $6.36B2008-12-31: $6.98B2009-12-31: $7.42B2010-12-31: $8.01B2011-12-31: $8.42B2012-12-31: $9.20B2013-12-31: $9.87B2014-12-31: $10.84B2015-12-31: $11.41B2016-12-31: $12.13B$12.13B
2007-12-31 Cost of Revenue (USD) 2016-12-31
Period endedCost of RevenueChange YoYSource filing
2016-12-31$12.13B+6.4%2017-02-22, From 2016-01-01
2015-12-31$11.41B+5.3%2017-02-22, From 2015-01-01
2014-12-31$10.84B+9.8%2017-02-22, From 2014-01-01
2013-12-31$9.87B+7.3%2016-02-24, From 2013-01-01
2012-12-31$9.20B+9.3%2015-02-25, From 2012-01-01
2011-12-31$8.42B+5.1%2014-02-25, From 2011-01-01
2010-12-31$8.01Bn/c2013-02-26, From 2010-01-01
2009-12-31$7.42B+6.2%2012-02-23, From 2009-01-01
2008-12-31$6.98B+9.7%2011-03-25, From 2008-01-01
2007-12-31$6.36Bn/a2010-02-24, From 2007-01-01